Singapore markets open in 7 hours 52 minutes
  • Straits Times Index

    3,092.11
    -6.14 (-0.20%)
     
  • S&P 500

    4,575.36
    +62.32 (+1.38%)
     
  • Dow

    34,639.67
    +617.63 (+1.82%)
     
  • Nasdaq

    15,347.91
    +93.86 (+0.62%)
     
  • BTC-USD

    56,413.91
    -2,152.35 (-3.68%)
     
  • CMC Crypto 200

    1,435.94
    -2.95 (-0.20%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Gold

    1,767.60
    -16.70 (-0.94%)
     
  • Crude Oil

    66.31
    +0.74 (+1.13%)
     
  • 10-Yr Bond

    1.4530
    +0.0190 (+1.32%)
     
  • Nikkei

    27,753.37
    -182.25 (-0.65%)
     
  • Hang Seng

    23,788.93
    +130.01 (+0.55%)
     
  • FTSE Bursa Malaysia

    1,501.74
    +4.81 (+0.32%)
     
  • Jakarta Composite Index

    6,583.82
    +76.14 (+1.17%)
     
  • PSE Index

    7,032.54
    +85.48 (+1.23%)
     

SHAREHOLDER ALERT: Robbins LLP Announces that InnovAge Holdings Corp. (INNV) is Being Sued for Misleading Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, October 18, 2021--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired InnovAge Holdings Corp. (NASDAQ: INNV ) securities pursuant to the Company's March 2021 initial public offering ("IPO"), for violations of the Securities Act of 1933. InnovAge operates a healthcare delivery platform that purports to take a "patient-centered care approach" to improve the quality of care that participants receive.

If you suffered a loss due to InnovAge Holding Corp.'s misconduct, click here.

InnovAge Holdings Corp. (INNV) Misstated its Operational and Business Prospects in its Offering Documents

According to the complaint, on March 5, 2021, InnovAge conducted its IPO, selling its shares at $21.00 per share for proceeds of approximately $373.6 million. On September 21, 2021, InnovAgre revealed that the Centers for Medicare and Medicaid Services had "determined to freeze new enrollments at [the Company's] Sacramento center based on "deficiencies detected in [a recent] audit." It stated that these "deficiencies relate to failures to provide covered services, provide accessible and adequate services, manage participants' medical situations, and oversee use of specialists, among others." On this news, the stock price fell $2.90 per share, or 25%, to close at $8.75 per share on September 22, 2021. The stock now trades at just $6.30 per share, a significant decline from the $21 per share IPO price.

If you purchased shares of InnovAge Holdings Corp. (INNV) pursuant to the Company's March 5, 2021 IPO, you have until December 13, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against InnovAge Holdings Corp. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211018005988/en/

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting